Rossari Biotech in focus, here’s why
In a few ideas for profit from Moneycontrol Pro, Anubhav Sahu of Moneycontrol.Com spoke about a stock that he is tracking closely, Rossari Biotech.
In a few ideas for profit from Moneycontrol Pro, Anubhav Sahu of Moneycontrol.Com spoke about a stock that he is tracking closely, Rossari Biotech.
The specialty chemicals manufacturer recently announced two back-to-back inorganic deals. Tristar Intermediates will help Rossari Biotech in getting access to personal care additives portfolio.
The company’s inorganic strategy is aimed at complementary attributes.
The commissioning of Dahej facility provides profound capacity headroom. However, in terms of valuations, the stock trades at about 39 times EV/EBITDA of FY23 which is at a premium compared to larger peers.
The stock is up about 60 percent from its October levels and it may be prudent to take some profits off the table and wait for lower levels.
Watch the accompanying video, for more details.
(Edited by : Abhishek Jha)
First Published: Jul 27, 2021 4:07 PM IST
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
BJP is planning to ban RSS, says Shiv Sena (UBT) chief Uddhav Thackeray
May 18, 2024 8:01 PM
Punjab Lok Sabha elections: Complete list of Congress candidates
May 18, 2024 4:08 PM
Punjab Lok Sabha elections: Check full list of AAP candidates and constituencies
May 18, 2024 12:59 PM
PM Modi, Rahul Gandhi election rallies in Delhi today: Here are the routes to avoid
May 18, 2024 11:28 AM